Patient no. | Age (y) | Sex | Tumor type | Previous treatment* |
1 | 59 | M | Follicular thyroid cancer | Isotretinoin redifferentiation therapy |
2 | 66 | M | Neuroendocrine tumor | 90Y-DOTATOC therapy |
3 | 60 | M | Neuroendocrine tumor | Sandostatin therapy |
4 | 56 | M | Neuroendocrine tumor | Transabdominal chemoembolization |
5 | 74 | M | Neuroendocrine tumor | Hemihepatectomy |
* 111In-DTPA-octreotide and 111In-DOTA-BASS scans were performed more than 3 mo after termination of treatment.